Singing River Hospital

Summary

Singing River Hospital is a medical facility located in Pascagoula, Mississippi. This center is recognized for care of Breast Cancer, Breast cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cervical Cancer and other specialties. Singing River Hospital is involved with conducting 91 clinical trials across 135 conditions. There are 2 research doctors associated with this hospital, such as James E. Clarkson and Michael A. Finan.

Top PIs

Clinical Trials running at Singing River Hospital

Breast cancer

Breast Cancer

Cardiotoxicity

Cancer

Brain Tumor

Brain Metastasis

HER2 Positive

No change needed.

HER2 Negative

Progesterone Receptor Positive

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (currently open to accrual) is observational, and contains patients who are taking a beta blocker, ACE inhibitor, or ARB as well as their trastuzumab-based treatment. The goal is to understand how common cardiac problems are in this group of patients at high risk. The smaller cohort (currently closed to accrual) is randomized. Patients in this second cohort are randomized to either carvedilol or no treatment, with the goal of seeing whether carvedilol (used to treat heart failure and high blood pressure) may prevent the heart from side effects of chemotherapy.

Recruiting

2 awards

Phase 3

23 criteria

Marker-Directed Monitoring

for Breast Cancer

This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.

Recruiting

1 award

N/A